CD8A and neoplasm: Graft-versus-tumor effect in a ccRCC patient who underwent hematopoietic stem cell transplantation led to the identification of a HERV-E provirus on chromosome 6q15 (also known as CT-RCC) as the source of the tumor-associated epitope targeted by donor CD8+ T cells (120).